The researchers found that, compared with patients without HCV, patients with HCV are not only at increased risk of liver cancer but of other cancers, including non-Hodgkin lymphoma and prostate and renal cancers.
Based on an analysis from the SEER database, regional lymph node involvement in patients isassociated with an inferior overall outcome when compared with patients without regional lymph node involvement.[38].
In renal failure, severe(CC 10-30 ml/ min) the AUC of dabigatran and T1/ 2 increases, respectively,6 and 2 times compared with patients without renal failure.
Compared to patients with the same illness, age and other characteristics who don't develop delirium, those who do are almost three times more likely to die during, or soon after, hospitalisation.
In fact, patients who were treated with Lutathera in the clinical trial had a 79 percent reduction in risk of disease progression ordeath, as compared to patients treated with octreotide alone.”.
In clinical trials lasting from 6 months to 1 year, patients with overweight or obesity and type 2 diabetes mellitus taking orlistatshowed greater body weight loss compared to patients treated with diet therapy alone.
In a large confirmatory intergroup trial, levamisole/5-FU- prolonged DFS andOS in patients with stage III colon cancer compared with patients who received no treatment after surgery.
In patients with hepatic insufficiency was an increase in T1/ 2(26.6, 35.3 and 46.1 h for mild hepatic insufficiency,moderate and severe classification Child-Pugh respectively), compared to patients with normal liver function.
In patients with schizophrenia receiving Azaleptin, the frequency of suicide attempts andsuicide is significantly reduced compared with patients who did not receive clozapine(in epidemiological studies the frequency of suicide attempts when clozapine was reduced by more than 7 times compared with patients not receiving clozapine).
Compared to patients who were treated within 30 days,patients with stage I melanoma were 5% more likely to die when treated between 30 and 59 days; 16% more likely to die when treated between 60 and 89 days; 29% more likely to die when treated between 91 and 120 days; and 41% more likely to die when treated after 120 days.
このレトロスペクティブ・レビューでは、比較的年齢の高いNHL患者と比較して乳児の転帰が劣っていた。
In this retrospective review, the outcome for infants was inferior compared with the outcome for older patientswith NHL.
この標準リスク患者と比較して低い生存率は、主に早期の死亡イベントに起因していた。
This lower survival compared with standard-risk patients was primarily caused by early death events.
AF-HFrEF患者と比較して、AF-HFpEF患者は高齢かつ女性である傾向が認められた。
Compared to the patients with AF-HFrEF, those with AF-HFpEF were older and more likely to be female.
レビューでは、比較的年齢の高いNHL患者と比較して乳児の転帰が劣っていた。[6]。
In this retrospective review, the outcome for infants was inferior compared with the outcome for older patientswith NHL.[6].
As AD has a tendency to heal naturally,the long-term efficacy of TCS in AD management should be compared with the outcomes seen in patientswith AD not using TCS.
One patient in the intensive-therapy grouphad progression to end-stage renal disease, as compared with six patients in the conventional-therapy group(P=0.04).
日本語
中文
عربى
Български
বাংলা
Český
Dansk
Deutsch
Ελληνικά
Español
Suomi
Français
עִברִית
हिंदी
Hrvatski
Magyar
Bahasa indonesia
Italiano
Қазақ
한국어
മലയാളം
मराठी
Bahasa malay
Nederlands
Norsk
Polski
Português
Română
Русский
Slovenský
Slovenski
Српски
Svenska
தமிழ்
తెలుగు
ไทย
Tagalog
Turkce
Українська
اردو
Tiếng việt